CRO Intel

Dashboard Companies Opportunity Signals Clinical Trials Hiring Intelligence Funding Publications FDA Settings

Company Intelligence

Discover companies with clinical, regulatory and hiring signals
Total Companies

6,643

Company Clinical Trials FDA Signals Hiring Opportunity Confidence Last Seen
Kadmon Pharmaceuticals — — —
60
40% 		7/20/2026 View Intelligence
Kai Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kaifeng Pharmaceutical (group) — — —
60
36% 		7/17/2026 View Intelligence
Kairos Pharma — — —
60
36% 		7/17/2026 View Intelligence
Kaken Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Kala Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kaleido Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Kali Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Kaligia Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Kalivir Immunotherapeutics — — —
60
36% 		7/17/2026 View Intelligence
Kalvista Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kalyra Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kalytera Therapeutics Israel — — —
60
36% 		7/17/2026 View Intelligence
Kamau Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Kamedis — — —
60
40% 		7/20/2026 View Intelligence
Kanchan Healthcare — — —
60
40% 		7/20/2026 View Intelligence
Kaneka Pharma Europe 1 trials — —
60
36% 		7/17/2026 View Intelligence
Kangen Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kangpu Biopharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kanisa Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kao USA — — —
60
42% 		7/20/2026 View Intelligence
Kare Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Kariya Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Karl-franzens-universität Graz Institute Of Molecular Biosciences Graz Austria — — —
60
36% 		7/17/2026 View Intelligence
Karl-franzens-universität Institute Of Molecular Biosciences Graz Austria — — —
60
36% 		7/17/2026 View Intelligence
Karo Healthcare — — —
60
40% 		7/20/2026 View Intelligence
Karo Pharma — — —
60
36% 		7/17/2026 View Intelligence
Karos Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kartos Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Karuna Therapeutics A Bristol Myers Squibb — — —
60
36% 		7/17/2026 View Intelligence
Karus Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Karyopharm Therapeutics 1 trials — —
60
36% 		7/17/2026 View Intelligence
Kashiv Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Kastle Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Katmai Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kato Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kaz USA — — —
60
40% 		7/20/2026 View Intelligence
Kazia Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Kazm Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Kbp Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Kd Pharma Group — — —
60
36% 		7/17/2026 View Intelligence
Kechow Pharma — — —
60
36% 		7/17/2026 View Intelligence
Kel-San — — —
60
40% 		7/20/2026 View Intelligence
Kelonia Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Kenai Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Kenvue Brands — — —
60
42% 		7/20/2026 View Intelligence
Keri Pharma Hungary Kft — — —
60
36% 		7/17/2026 View Intelligence
Kern Pharma Sl — — —
60
36% 		7/17/2026 View Intelligence
Keros Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Keryx / Aoi Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Showing 3201 - 3250 of 6,643 companies